Please login to the form below
venture capital
This page shows the latest venture capital news and features for those working in and with pharma, biotech and healthcare.
UK biotech funding falls 40% between 2018 and 2019
Out of that amount, £679m was raised in venture capital, £64m was raised in Initial Public Offerings (IPOs) and £596m in all other public financings. ... According to the report, global venture capital deals totalled £14.5bn in 2019, down 12%, with
Latest news
-
Merck acquires pre-clinical biotech Calporta for up to $576m
Calporta was one of eight San Diego-based biotechs created as part of a deal between venture capital firm Avalon Ventures and pharma giant GlaxoSmithKline. ... COI Pharmaceuticals is the venture-pharma entity established by Avalon to support its
-
Amgen exits neuroscience R&D to focus on growth areas
example through its collaboration with deCode Genetics, and will be “exploring potentially different models for doing that with venture capital and perhaps academic institutions as well”.
-
Biogen’s R&D chief Ehlers heads for the exit
Along with his CEO role at Limelight, Ehlers is also taking on a CSO position at venture capital firm Apple Tree.
-
Johnson pledges £200m cash injection into UK’s life sciences sector
The investment aims to help companies within the sector to raise capital – to run clinical trials, employ more industrial scientists and develop manufacturing capabilities. ... He added “this is particularly important in the coming weeks as UK-based
-
Mega-mergers dominate as buoyant markets lift biopharma
Venture capital is also fuelling biotech funding, with $3bn raised in Q2.
More from news
Approximately 2 fully matching, plus 106 partially matching documents found.
Latest Intelligence
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
Larger pharmaceutical companies also have relied on hybrid venture capital firms, corporate venture capital arms and/or incubators for sourcing R&D innovation. ... For example, GlaxoSmithKline, one of the early movers in this space, founded the venture
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
The cell therapy, gene therapy and tissue engineering sector raised $2.9bn in venture capital in 2018 – twice the 2017 amount.
-
Switzerland: a life sciences hub
Approximately 40% of the capital of European life sciences companies is traded on the SIX Swiss exchange – a reflection of Switzerland’s historical ties with the sector. ... The main struggle for these start-ups is access to sufficient venture capital
-
AI: the smart money is on the smart thinking
This is coupled with venture capital (VC) being increasingly attracted to the sector. ... Therefore, it is highly likely that Big Pharma and venture capital will continue to target AI-focused companies in the coming months and years.
-
The search for treatments for Parkinson’s disease
is ignited by smaller biotechs, funded by venture capital, start-ups and academia. ... Pfizer itself established a venture capital organisation to fund early-stage projects.
More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
Skinner joins the AMR Action Fund with extensive biomedical and investment funding experience, having spent decades in the biomedical research, venture and the pharmaceutical industries. ... Most recently, he served as the senior vice president of
-
New hires at EMA, Gilead and BeiGene
Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.
-
AstraZeneca taps internal candidate to become UK president
Prior to joining AZ, Keith-Roach worked in technology venture capital and strategy consulting for a period of ten years.
-
Recruiters PIR International appoint four new executives
He has a track record of delivering global retained search assignments at executive and board level, partnering with venture capital and private equity funded growth stage businesses to drive patient centric
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
He has held roles for Hovione Capital, a life science focused venture capital company, and has served on several life science company boards.
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Newcells Biotech secures over £5m for 3D tissue models
The funding comes from two existing backers. Mercia has invested from its Northern Venture Capital Trust (VCT) and Enterprise Investment Scheme (EIS) funds and the North East Venture Fund (NEVF), which
-
University spin-out fund makes half a million pound first investments
There are plans for the fund to be the nucleus of a larger venture capital fund, which is in the early stages of development.
-
Random42 Attending Jefferies 2018 London Healthcare Conference
This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.
-
Random42 appoints Bill Collis as Chairman
He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.
-
Managing value: Why early asset development and commercialization is important
Investors understand that it’s a gamble, but like every gambler they want the best odds. The figures really are staggering: there are companies with assets in development that have capital ... But while venture capital investors are pumping many
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Gene Editing and Precision Medicine: The Future of Healthcare?
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
Quick links
Infographics
